A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Table of Contents Sanuwave is a medical device company providing directed energy products into the wound care space. Our mission is to improve patient lives and outcomes by developing and marketing effective, easy to use products to decrease wound burden, lessen healing times, and reduce patient pain. Our focus is regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The Company’s patented and FDA cleared products include the UltraMIST® system (UM) and the PACE® family of products, both of which are used to treat a variety of acute and chronic wounds. These products are backed by an intellectual property (“IP”) portfolio of over 165 patents. In the year ended December 31, 2024, we had total revenues of $32.6 million, a 60% increase from revenues of $20.4 million in the year ended December 31, 2023.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 41M | 33M | 20M | 17M | - | - |
| Net Income | -7.0M | -31M | -26M | -10M | -27M | -31M |
| EPS | $-0.73 | $-7.03 | $-12.19 | $-0.02 | $-0.05 | $-0.08 |
| Free Cash Flow | -784K | 2.0M | -4.5M | -17M | -6.4M | -13M |
| ROIC | 119.1% | 14.2% | -90.9% | -35.6% | -60.0% | -86.5% |
| Gross Margin | 78.3% | 75.2% | 70.4% | 74.1% | - | - |
| Debt/Equity | 0.00 | -3.37 | -1.52 | -1.48 | -0.02 | -0.01 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 6.9M | 5.4M | -26M | -9.0M | -14M | -25M |
| Operating Margin | 16.6% | 16.6% | -126.5% | -53.5% | - | - |
| ROE | 0.0% | - | - | - | - | - |
| Shares Outstanding | 9M | 4M | 9M | 515M | 545M | 387M |
SANUWAVE Health, Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 73.3%.
SANUWAVE Health, Inc. (SNWV) has a 5-year average return on invested capital (ROIC) of -51.8%. This is below average and may indicate limited pricing power.
SANUWAVE Health, Inc. (SNWV) has a market capitalization of $150M. It is classified as a small-cap stock.
SANUWAVE Health, Inc. (SNWV) does not currently pay a regular dividend.
SANUWAVE Health, Inc. (SNWV) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
SANUWAVE Health, Inc. (SNWV) reported annual revenue of $33 million in its most recent fiscal year, based on SEC EDGAR filings.
SANUWAVE Health, Inc. (SNWV) has a net profit margin of -96.1%. The company is currently unprofitable.
SANUWAVE Health, Inc. (SNWV) generated $2 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
SANUWAVE Health, Inc. (SNWV) reported earnings per share (EPS) of $-7.03 in its most recent fiscal year.
SANUWAVE Health, Inc. (SNWV) has a 5-year average gross margin of 73.3%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 14 years of financial data for SANUWAVE Health, Inc. (SNWV), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
SANUWAVE Health, Inc. (SNWV) has a book value per share of $-2.85, based on its most recent annual SEC filing.